Sophie Hellé

A Pilot Study on Continuous Infusion of 4% Albumin in Critically Ill Patients: Impact on Nosocomial Infection via a Reduction Mechanism for Oxidized Substrates

A. Corti, P. Schaaf, F. Boulmedais, 2019, Critical care explorations.

Assessment of plasma Catestatin in COVID-19 reveals a hitherto unknown inflammatory activity with impact on morbidity-mortality

R. Clere-Jehl, Y. Goumon, M. Metz-Boutigue, 2022, Frontiers in Immunology.

Adrenal gland-released Vasostatin-I is a myocardial depressant factor.

M. Metz-Boutigue, F. Schneider, Jean-Etienne Herbrecht, 2019, British journal of clinical pharmacology.

In Trauma Patients, the Occurrence of Early-Onset Nosocomial Infections is Associated With Increased Plasma Concentrations of Chromogranin A

O. Rohr, M. Guillot, F. Schneider, 2017, Shock.

Catestatin in innate immunity and Cateslytin-derived peptides against superbugs

S. Chasserot-Golaz, S. Cianférani, J. Strub, 2021, Scientific Reports.

The Catestatin-Derived Peptides Are New Actors to Fight the Development of Oral Candidosis

P. Lavalle, M. Metz-Boutigue, F. Scavello, 2022, International journal of molecular sciences.